Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p4 | Arthritis and other joint diseases: translational and clinical | ECTS2016

Immune system and bone cells in early rheumatoid arthritis

Buondonno Ilaria , Sassi Francesca , Rigoni Micol , Rovera Guido , Isaia Giovanni Carlo , D'Amelio Patrizia

Rheumatoid arthritis (RA) is an immune-mediated disease characterized by T cells activation and bone erosions that severely reduces patients quality of life; however a clear role for different T helper (Th) cells has not been established yet.This work aims to evaluate Th phenotypes, osteoclast (OCs) precursors cells and cytokines in peripheral blood of women affected by early RA (eRA) compared to healthy women matched for age. The study was approved by o...

ba0005p147 | Cell biology: osteoblasts and bone formation | ECTS2016

Skin-derived IL-17A induces bone loss in the absence of adaptive immunity

Uluckan Ozge , Schnabl Jakob , Jimenez Maria , Jeschke Anke , Karbach Susanne , Schinke Thorsten , Waisman Ari , Schett Georg , Wagner Erwin

Inflammatory stimuli can lead to bone loss by mechanisms that are not well understood. We recently showed that skin inflammation induces bone loss in mice and humans. In psoriasis, one of the prototypic IL-17A-mediated inflammatory human skin diseases, low bone formation and bone loss correlates with increased serum IL-17A levels. Similarly, in two mouse models with chronic IL-17A-mediated skin inflammation, K14-IL17Aind and JunB&...

ba0005p279 | Nutrition | ECTS2016

Association between lean mass and dietary protein intake in postmenopausal women

Povoroznyuk Vladyslav , Dzerovych Nataliia , Povorooznyuk Roksolana

The aim of the study was to evaluate the appendicular lean mass depending on the dietary protein intake in the Ukrainian postmenopausal women.Materials and methods: The study involved 63 women aged 52–89 years, who, depending on their ages, were divided into groups: 52–59 years (n=9), 60–69 years (n=26), 70–79 years (n=21), 80–89 years (n=7). To assess the dietary habits of women, we used the t...

ba0005p287 | Osteoporosis: evaluation and imaging | ECTS2016

Indentification of the lumbar 1-4 and lumbar 2-4 bone mineral density in women

Shao Hongyu , Yu Wei , Sun Pengtao , Du Guiying

Introduction: Osteoporosis is a major bone disease among postmenopausal women. Measurement of BMD in the spine and hip is used as gold standard for the diagnosis of osteoporosis. ISCD recommended that posteroanterior L1-4 as the spine region of interest for BMD measurement. However, both L1-4 and L2-4 are used in the clinical and epidemiological studies. The aim of our study was to evaluate whether the differences of BMD between L1-4 and L2-4 would exist.<p class="abstext"...

ba0005p295 | Osteoporosis: evaluation and imaging | ECTS2016

Risk factors for subsequent vertebral compression fracture following osteoporotic compression fracture

Soo Kim Sung , Hwan Kim Jin , Hoon Kim Jung , Wan Choi Byung , Hyun Lee Dong

Objectives: To evaluate risk factors of subsequent vertebral fracture following acute osteoporotic vertebral compression fracture.Methods: As a multicenter retrospective study, we recruited 135 patients treated for acute osteoporotic compression fracture with available spine image taken at 1-year follow-up in three hospitals. The patients were divided into two groups according to occurrence of subsequent vertebral fracture. Two groups were analyzed with ...

ba0005p350 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Bone mineral density in women with Parkinson’s disease

Povoroznyuk Vladyslav , Bystrytska Maryna , Karaban' Irina , Karasevych Nina

Aim: The aim of the research is to define the bone mineral density in patients, with Parkinson’s disease.Methods: We examined 12 women with Parkinson’s disease and 12 healthy women of appropriate age (average age: −63.6±6.25 vs 62.2±6.83 years, P=0.5). The duration of Parkinson’s disease was at list 5 years. All patients reseived levodopa.Results: BMD of women with Parkinson’s disease wa...

ba0006p167 | (1) | ICCBH2017

Stable and functional osteosynthesis with intramedullary growing rods: results of surgical correction in eleven patients with systemic skeletal disease

Zyma Andrii , Guk Iurii , Martsynyak Stepan , Stewart David , Cheverda Andrii , Kincha-Polishchuk Tamara , Demyan Yuriy

Goal: The use of intramedullary telescopic constructs for osteosynthesis in surgical correction of bone deformities in children with systemic skeletal disease can be complicated by delayed bony union, and the structural and functional pathology of bone in patients with these disorders do not always make it possible to avoid displacement of bone fragments and effectively correct the deformity.Methods: Analysis of treatment of 11 patients of femoral and ti...

ba0007p36 | (1) | ICCBH2019

ALPL gene mutation in a family

Vai Silvia , Broggi Francesca , Luisa Bianchi Maria , Ponti Emanuela , Mihalich Alessandra , Maria Di Blasio Anna

Introduction: The clinical diagnosis of mild forms of hypophosphatasia [HPP], a rare genetic bone disease, is often made in adulthood, on the basis of persistently low serum levels of alkaline phosphatase [ALP], often coupled with signs of poor bone/teeth mineralization.Case report: A 50-year-old male on treatment with vitamin D supplementation because of osteoporosis of lumbar spine (T-score –3.2) and femoral neck (T-score –2.4), was referred ...

ba0002p76 | (1) | ICCBH2013

Final height and bone health in young adults, transplanted in childhood

Dyck Maria Van , Herman Jean , Lombaerts Rita

: This study analyses the long-term effect of rhGH on final height (FH) and bone health in renal transplanted patients.Twenty-one young adult patients, aged 17–26 years, were studied. Group A consisted of 15 patients (12 boys) who received rhGH during 3.0 years before transplantation. After transplantation three boys needed rhGH again for 3.5 years. In group B six patients (three boys) didn’t need rhGH before transplantation, three girls receiv...

ba0003pp356 | Osteoporosis: treatment | ECTS2014

Changes in lumbar spine QCT, DXA and TBS with denosumab, alendronate or placebo in postmenopausal women with low bone mass

Thomas Thierry , Cheung Angela M , Shane Elizabeth , Zanchetta Jose R , Kearns Ann , Hans Didier , Lin Celia J F , Austin Matthew , Libanati Cesar

Patients with osteoporosis require treatment with therapies that reduce the risk of fracture which at the spine is significantly influenced by bone microarchitecture. Quantitative computed tomography (QCT) and dual X-ray absorptiometry (DXA) allow measurement of bone mineral density (BMD), a known indicator of fracture risk. Trabecular bone score (TBS) is a novel gray-level measurement derived from spine DXA image texture that is related to microarchitecture and associates wit...